METABOLISM OF PYRAZINAMIDE. PYRAZINAMIDE DEAMIDASE OF ANIMAL TISSUESTOIDA I.1973; AMER. REV. RESP. DIS.; U.S.A.; DA. 1973; VOL. 107; NO 4; PP. 630-638; BIBL. 19 REF.Serial Issue

Automated Chemiluminometric Screening of Counterfeit Drugs of the Antituberculosis Agent PyrazinamidePRIOR, Joao A. V; SANTOS, Joao L. M; LIMA, José L. F. C et al.Journal of AOAC International. 2009, Vol 92, Num 3, pp 830-836, issn 1060-3271, 7 p.Article

Pyrazinamide-induced sideroblastic anemiaCOLUCCI, Giuseppe; SILZLE, Tobias; SOLENTHALER, Max et al.American journal of hematology. 2012, Vol 87, Num 3, issn 0361-8609, p. 305Article

Iron enhances the antituberculous activity of pyrazinamideSOMOSKOVI, Akos; WADE, Mary Margaret; ZHONGHE SUN et al.Journal of antimicrobial chemotherapy (Print). 2004, Vol 53, Num 2, pp 192-196, issn 0305-7453, 5 p.Article

EFFECT OF PYRAZINAMIDE ON NICOTINAMIDE ADENINE DINUCLEOTIDE GLYCOHYDROLASE OF TUBERCULOUS HOSTTOIDA I.1973; AMER. REV. RESP. DIS.; U.S.A.; DA. 1973; VOL. 107; NO 4; PP. 648-655; BIBL. 21REF.Serial Issue

SENSIBILITE DE BACILLES TUBERCULEUX A LA PYRAZINAMIDE DETERMINEE SUR LA BASE DE LEUR SENSIBILITE A LA NICOTINAMIDE ET DE LEURS ACTIVITES DE PYRAZINAMIDASE ET NICOTINAMIDASETATAR J.1974; GRUZLICA CHOR. PLUC; POLSKA; DA. 1974; VOL. 42; NO 8; PP. 773-777; ABS. RUSSE ANGL.; BIBL. 8REF.Article

Fluoroquinolone and pyrazinamide resistance in multidrug-resistant tuberculosisPIERRE-AUDIGIER, C; SURCOUF, C; CADET-DANIEL, V et al.The International journal of tuberculosis and lung disease. 2012, Vol 16, Num 2, pp 221-223, issn 1027-3719, 3 p.Article

Réaction cutanée après une prise de pyrazinamide = Cutaneous reaction after pyrazinamide initiationMULLIEZ, P; MBASSI FOUDA, F.-L; ROY SAINT-GEORGES, F et al.Médecine et maladies infectieuses. 2011, Vol 41, Num 9, pp 499-500, issn 0399-077X, 2 p.Article

Hepatotoxicity of Pyrazinamide : Cohort and Case-Control AnalysesCHANG, Kwok C; LEUNG, Chi C; YEW, Wing W et al.American journal of respiratory and critical care medicine. 2008, Vol 177, Num 12, pp 1391-1396, issn 1073-449X, 6 p.Article

TUBERCULOSE PULMONAIRE RESISTANTE A LA STREPTOMYCINE + ISONIAZIDE ET TRAITEE PAR L'ASSOCIATION ETHIONAMIDE, PYRAZINAMIDE ET CYCLOSERINE. (A PROPOS DE 200 CAS)BARTAL M; NEJJAR A; LARAKI A et al.1973; TUNISIE MED.; TUNISIE; DA. 1973; NO 4; PP. 237-243; BIBL. 12REF.Article

SENSIBILITE DE BACILLES TUBERCULEUX A LA PYRAZINAMIDE DETERMINEE SUR LA BASE DE LEUR SENSIBILITE A LA NICOTINAMIDETATAR J.1974; GRUZLICA CHOR. PLUC; POLSKA; DA. 1974; VOL. 42; NO 8; PP. 765-771; ABS. RUSSE ANGL.; BIBL. 19REF.Article

Effects of low incubation temperatures on the bactericidal activity of anti-tuberculosis drugsCOLEMAN, David; WADDELL, Simon J; MITCHISON, Denis A et al.Journal of antimicrobial chemotherapy (Print). 2011, Vol 66, Num 1, pp 146-150, issn 0305-7453, 5 p.Article

SHORT-COURSE CHEMOTHERAPY FOR PULMONARY TUBERCULOSIS.FOX W; MITCHISON DA.1975; AMER. REV. RESP. DIS.; U.S.A.; DA. 1975; VOL. 111; NO 6; PP. 845-848Article

TREATMENT OF RESISTANT PULMONARY TUBERCULOSIS IN HONG KONG WITH REGIMENS OF SECOND-LINE DRUGSHORSFALL PAL.1972; TUBERCLE; G.B.; DA. 1972; VOL. 53; NO 3; PP. 166-173; ABS. FR. ESP. ALLEM.; BIBL. 11REF.Serial Issue

EFFECTS OF DRUGS ON URIC ACID IN MAN = EFFETS DES MEDICAMENTS SUR L'ACIDE URIQUE CHEZ L'HOMMEKELLEY WN.1975; ANNU. REV. PHARMACOL.; U.S.A.; DA. 1975; VOL. 15; PP. 327-350; BIBL. 4 P.Article

ACTIVITE DES ALDOLASES ET DES TRANSAMINASES SERIQUES DES MALADES ATTEINTS DES FORMES DESTRUCTRICES CHRONIQUES DE TUBERCULOSE PULMONAIRE AU COURS DE LEUR TRAITEMENT PAR LE PROTIONAMIDEKALABUKHA AV; IZABOLINSKAYA RM.1973; PROBL. TUBERK.; S.S.S.R.; DA. 1973; NO 1; PP. 46-48; ABS. ANGL.; BIBL. 10REF.Serial Issue

UNA COMPARACION CONTROLADA DE REGIMEN DE UNA DOSIS O DOS DOSIS SEMANALES EN EL TRATAMIENTO INICIAL DE LA TUBERCULOSIS PULMONAR = UNE COMPARAISON CONTROLEE DU REGIME A UNE OU DEUX DOSES HEBDOMADAIRES DANS LE TRAITEMENT INITIAL DE LA TUBERCULOSE PULMONAIREsdREV. ARGENT. TUBERC. ENFERM. PULMON.; ARGENT.; DA. 197; VOL. 33; NO 1-2; PP. 49-53Serial Issue

Mutually Exclusive Genotypes for Pyrazinamide and 5-Chloropyrazinamide Resistance Reveal a Potential Resistance-Proofing StrategyBAUGHN, Anthony D; JIAOYU DENG; VILCHEZE, Catherine et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 12, pp 5323-5328, issn 0066-4804, 6 p.Article

A Novel Mechanism Underlies the Hepatotoxicity of PyrazinamideSHIH, Tung-Yuan; PAI, Chien-Yi; PING YANG et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 4, pp 1685-1690, issn 0066-4804, 6 p.Article

IMPROVED METHOD FOR TESTING SUSCEPTIBILITY OF MYCOBACTERIUM TUBERCULOSIS TO PYRAZINAMIDEBUTLER WR; KILBURN JO.1982; JOURNAL OF CLINICAL MICROBIOLOGY; ISSN 0095-1137; USA; DA. 1982; VOL. 16; NO 6; PP. 1106-1109; BIBL. 14 REF.Article

AGRANULOCYTOSE ET DYSTROPHIE HEPATIQUE TOXIQUE AU COURS D'UN TRAITEMENT ANTITUBERCULEUXRABINA EH V; SAMICHASTNOVA AG; GOLUBYATNIKOVA GA et al.1972; ARKH. PATOL.; S.S.S.R.; DA. 1972; VOL. 34; NO 8; PP. 75-77; ABS. ANGL.; BIBL. 1/2 P.Serial Issue

EXACERBATION OF PORPHYRIA DURING TREATMENT OF PULMONARY TUBERCULOSISTREECE GL; MAGNUSSEN CR; PATTERSON JR et al.1976; AMER. REV. RESP. DIS.; U.S.A.; DA. 1976; VOL. 113; NO 2; PP. 233-237; BIBL. 15 REF.Article

FIRST-LINE CHEMOTHERAPY IN THE RETREATMENT OF BACTERIOLOGICAL RELAPSES OF PULMONARY TUBERCULOSIS FOLLOWING A SHORT-COURSE REGIMEN1976; LANCET; G.B.; DA. 1976; NO 7952; PP. 162-163; BIBL. 11 REF.Article

ETUDE DE L'ABSORPTION ET DE L'ELIMINATION URINAIRE DU PYRAZINAMIDE ADMINISTRE SEUL OU EN ASSOCIATION AVEC L'ISONIAZIDE ET LA RIFAMPICINEFADILA BOULAHBAL; SAFIA KHALED; HAFIZA BOUHASSEN et al.1978; ARCH. INST. PASTEUR ALGERIE; ISSN 0020-2460; DZA; DA. 1978-1979; VOL. 53; PP. 165-185; ABS. ENG; BIBL. 13 REF.Article

EFFICACITE D'UN TRAITEMENT ALTERNATIF DE LA TUBERCULOSE (ETUDE EXPERIMENTALE)DRABKINA RO.1976; PROBL. TUBERK.; S.S.S.R.; DA. 1976; NO 3; PP. 62-67; ABS. ANGL.; BIBL. 2 REF.Article